Bottom line
How much do GGHCX and LHCOX overlap?
49% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 38.3% of GGHCX's assets and 38.4% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings GGHCX and LHCOX have in common
| Holding | % of GGHCX | % of LHCOX | Overlap |
|---|---|---|---|
| Eli Lilly and Co. | 10.59% | 10.40% | 10.40% |
| Johnson & Johnson | 6.76% | 4.96% | 4.96% |
| UnitedHealth Group Inc. | 6.17% | 5.39% | 5.39% |
| Gilead Sciences, Inc. | 3.63% | 3.53% | 3.53% |
| CVS Health Corp. | 2.52% | 3.33% | 2.52% |
| Guardant Health, Inc. | 2.04% | 2.61% | 2.04% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.24% | 2.01% |
| Edwards Lifesciences Corp. | 1.56% | 1.78% | 1.56% |
| Thermo Fisher Scientific Inc. | 1.55% | 2.31% | 1.55% |
| BridgeBio Pharma, Inc. | 1.43% | 1.84% | 1.43% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Cardinal Health, Inc. — 2.10%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Invesco Treasury Portfolio — 1.56%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Only in LHCOX
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Galderma Group AG — 2.60%
- Cogent Biosciences Inc — 2.27%
- 10X Genomics Inc — 2.16%
- BeOne Medicines Ltd — 2.06%
- Ascendis Pharma A/S — 1.99%
- AstraZeneca PLC — 1.97%
- Madrigal Pharmaceuticals Inc — 1.91%
- Revolution Medicines Inc — 1.67%
- Arrowhead Pharmaceuticals Inc — 1.52%
- Protagonist Therapeutics Inc — 1.44%
- Dianthus Therapeutics Inc — 1.44%
- Adaptive Biotechnologies Corp — 1.42%
- Illumina Inc — 1.42%
Asset mix
| Asset type | GGHCX | LHCOX |
|---|---|---|
| Stocks | 97.5% | 98.2% |
| Cash & short-term funds | 8.8% | 0.8% |
| Repurchase agreements | — | 1.2% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | GGHCX | LHCOX |
|---|---|---|
| US | 93.5% | 78.5% |
| CH | 2.7% | 8.8% |
| NL | 3.4% | 2.2% |
| GB | 3.1% | 2.0% |
| DK | 1.1% | 2.0% |
| BE | 1.2% | 1.4% |
| IL | 0.4% | 1.2% |
| JP | — | 1.2% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do GGHCX and LHCOX overlap?
What stocks do GGHCX and LHCOX have in common?
Should I own both GGHCX and LHCOX?
Which holds more stocks, GGHCX or LHCOX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.